Tom Buckland appointed as Chairman of the 4D Medicine Group Board
We are delighted to welcome Dr Tom Buckland to the 4D team. With a wealth of knowledge in the medical technology sector and experience in fundraising, developing and commercialising technologies, Tom will play a key role in guiding the 4D Board, as it oversees the group’s strategic journey. Tom has been instrumental in driving the rapid growth of university medtech spin-outs and leading them to successful exits. His first venture, ApaTech Limited, a spin-out form the University of London, was sold to Baxter International for $330m in 2010. Following this in 2020, Tom led Aberdeen University medtech spin-out, Sirakoss, to an exit worth $11m.
4D CEO Phil Smith said “I look forward to working closely with Tom over the coming months and years as we navigate our way towards our long term goals”.
